Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $8.04 USD
Change Today 0.00 / 0.00%
Volume 0.0
BEAT On Other Exchanges
As of 8:10 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

biotelemetry inc (BEAT) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/13/15 - $11.33
52 Week Low
05/7/14 - $6.42
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BIOTELEMETRY INC (BEAT)

Related News

No related news articles were found.

biotelemetry inc (BEAT) Related Businessweek News

No Related Businessweek News Found

biotelemetry inc (BEAT) Details

BioTelemetry, Inc. provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. It operates in three segments: Patient Services, Product, and Research Services. The Patient Services segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. This segment offers Mobile Cardiac Outpatient Telemetry service, which incorporates a lightweight patient-worn sensor attached to electrodes that capture two-channel electrocardiography (ECG) data, measuring electrical activity of the heart, on a compact wireless handheld monitor; event monitoring services to prescribe wireless event monitors, digital loop event monitors, memory loop event monitors, and non-loop event monitors; and a Holter monitor to cardiologists and electrophysiologists. The Product segment focuses on the manufacture, engineering, and development of noninvasive cardiac monitors for healthcare companies, clinics, and hospitals worldwide. This segment offers various devices, including cardiac event monitors, digital Holter monitors, and mobile cardiac telemetry monitors; and contract engineering and manufacturing services. The Research Services segment provides cardiac monitoring, scientific consulting, and data management services for drug and medical device trials to pharmaceutical companies, medical device companies, and contract research and academic research organizations. Its centralized services include ECG, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, protocol development, imaging services, and expert reporting and statistical analysis. This segment also offers support services, such as project coordination, setup and management, equipment rental, data transfer, processing, and analysis, as well as 24/7 customer support and site training. The company is headquartered in Malvern, Pennsylvania.

922 Employees
Last Reported Date: 02/23/15

biotelemetry inc (BEAT) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $535.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $338.0K
Chief Operating Officer and Senior Vice Presi...
Total Annual Compensation: $336.0K
Senior Vice President of Technical Operations
Total Annual Compensation: $320.0K
Senior Vice President of Corporate Developmen...
Total Annual Compensation: $310.0K
Compensation as of Fiscal Year 2014.

biotelemetry inc (BEAT) Key Developments

BioTelemetry, Inc. to Report Q1, 2015 Results on May 06, 2015

BioTelemetry, Inc. announced that they will report Q1, 2015 results at 4:00 PM, US Eastern Standard Time on May 06, 2015

BioTelemetry, Inc., Q1 2015 Earnings Call, May 06, 2015

BioTelemetry, Inc., Q1 2015 Earnings Call, May 06, 2015

BioTelemetry, Inc., Annual General Meeting, Apr 29, 2015

BioTelemetry, Inc., Annual General Meeting, Apr 29, 2015., at 08:30 US Eastern Standard Time. Location: the Radnor Hotel. Agenda: To consider and elect two Class II directors to hold office until the 2018 Annual Meeting of Stockholders or until their successors are elected and qualified; to consider and ratify the selection of Ernst & Young LLP as the company's independent registered public accounting firm for the year ending December 31, 2015; and to consider the any other business properly brought before the meeting and any adjournment or postponement of the meeting.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BEAT:US $8.04 USD 0.00

BEAT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
LifeWatch AG SFr.15.70 CHF +0.05
SHL TeleMedicine Ltd SFr.9.69 CHF +0.29
View Industry Companies

Industry Analysis


Industry Average

Valuation BEAT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.4x
Price/Book 3.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTELEMETRY INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at